By Esther Landhuis The antidepressant fluvoxamine (Luvox) may prevent hospitalization and death in outpatients with COVID-19, new research suggests. Results from the placebo-controlled, multisite, phase 3 TOGETHER trial showed that in COVID-19 outpatients at...
Antidepressant May Cut COVID-Related Hospitalization, Mortality: TOGETHER Published
read more